Annual Gross Profit
$37.54 B
+$5.58 B+17.47%
31 December 2023
Summary:
AstraZeneca annual gross profit is currently $37.54 billion, with the most recent change of +$5.58 billion (+17.47%) on 31 December 2023. During the last 3 years, it has risen by +$16.23 billion (+76.11%). AZN annual gross profit is now at all-time high.AZN Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$10.48 B
-$271.00 M-2.52%
30 September 2024
Summary:
AstraZeneca quarterly gross profit is currently $10.48 billion, with the most recent change of -$271.00 million (-2.52%) on 30 September 2024. Over the past year, it has increased by +$1.09 billion (+11.57%). AZN quarterly gross profit is now -2.52% below its all-time high of $10.76 billion, reached on 30 June 2024.AZN Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$41.42 B
+$1.09 B+2.70%
30 September 2024
Summary:
AstraZeneca TTM gross profit is currently $41.42 billion, with the most recent change of +$1.09 billion (+2.70%) on 30 September 2024. Over the past year, it has increased by +$5.28 billion (+14.62%). AZN TTM gross profit is now at all-time high.AZN TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.5% | +11.6% | +14.6% |
| 3 y3 years | +76.1% | +71.6% | +76.4% |
| 5 y5 years | +118.9% | +107.4% | +118.5% |
AZN Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +76.1% | -2.5% | +71.6% | at high | +76.4% |
| 5 y | 5 years | at high | +118.9% | -2.5% | +112.5% | at high | +118.5% |
| alltime | all time | at high | +304.3% | -2.5% | +880.6% | at high | +3773.9% |
AstraZeneca Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.48 B(-2.5%) | $41.42 B(+2.7%) |
| June 2024 | - | $10.76 B(+2.8%) | $40.33 B(+3.3%) |
| Mar 2024 | - | $10.46 B(+7.7%) | $39.03 B(+4.0%) |
| Dec 2023 | $37.54 B(+17.5%) | $9.72 B(+3.4%) | $37.54 B(+3.9%) |
| Sept 2023 | - | $9.40 B(-0.6%) | $36.13 B(+4.0%) |
| June 2023 | - | $9.46 B(+5.4%) | $34.74 B(+5.1%) |
| Mar 2023 | - | $8.97 B(+8.0%) | $33.05 B(+3.4%) |
| Dec 2022 | $31.96 B(+27.9%) | $8.31 B(+3.8%) | $31.96 B(+3.0%) |
| Sept 2022 | - | $8.00 B(+2.9%) | $31.04 B(+6.5%) |
| June 2022 | - | $7.77 B(-1.3%) | $29.15 B(+6.4%) |
| Mar 2022 | - | $7.88 B(+6.7%) | $27.40 B(+9.7%) |
| Dec 2021 | $24.98 B(+17.2%) | $7.39 B(+20.9%) | $24.98 B(+6.4%) |
| Sept 2021 | - | $6.11 B(+1.3%) | $23.48 B(+4.0%) |
| June 2021 | - | $6.03 B(+10.5%) | $22.58 B(+3.4%) |
| Mar 2021 | - | $5.46 B(-7.3%) | $21.84 B(+2.4%) |
| Dec 2020 | $21.32 B(+9.5%) | $5.88 B(+13.0%) | $21.32 B(+2.9%) |
| Sept 2020 | - | $5.21 B(-1.6%) | $20.72 B(+0.7%) |
| June 2020 | - | $5.29 B(+7.2%) | $20.57 B(+2.7%) |
| Mar 2020 | - | $4.93 B(-6.7%) | $20.04 B(+2.9%) |
| Dec 2019 | $19.46 B(+13.5%) | $5.29 B(+4.6%) | $19.46 B(+2.7%) |
| Sept 2019 | - | $5.05 B(+6.2%) | $18.96 B(+4.8%) |
| June 2019 | - | $4.76 B(+9.1%) | $18.09 B(+3.5%) |
| Mar 2019 | - | $4.36 B(-8.7%) | $17.47 B(+1.9%) |
| Dec 2018 | $17.15 B(-5.5%) | $4.78 B(+14.2%) | $17.15 B(+1.3%) |
| Sept 2018 | - | $4.19 B(+1.1%) | $16.93 B(-4.5%) |
| June 2018 | - | $4.14 B(+2.4%) | $17.72 B(+0.2%) |
| Mar 2018 | - | $4.04 B(-11.2%) | $17.68 B(-2.6%) |
| Dec 2017 | $18.15 B(-3.9%) | $4.55 B(-8.6%) | $18.15 B(+0.7%) |
| Sept 2017 | - | $4.98 B(+21.5%) | $18.02 B(+1.0%) |
| June 2017 | - | $4.10 B(-9.1%) | $17.84 B(-2.4%) |
| Mar 2017 | - | $4.51 B(+1.9%) | $18.28 B(-3.2%) |
| Dec 2016 | $18.88 B(-5.9%) | $4.42 B(-7.8%) | $18.88 B(-3.6%) |
| Sept 2016 | - | $4.80 B(+5.7%) | $19.58 B(-0.5%) |
| June 2016 | - | $4.54 B(-11.2%) | $19.69 B(-3.4%) |
| Mar 2016 | - | $5.11 B(-0.4%) | $20.39 B(+1.6%) |
| Dec 2015 | $20.06 B(-3.1%) | $5.13 B(+4.6%) | $20.06 B(+0.4%) |
| Sept 2015 | - | $4.90 B(-6.4%) | $19.98 B(-1.4%) |
| June 2015 | - | $5.24 B(+9.4%) | $20.27 B(-1.0%) |
| Mar 2015 | - | $4.79 B(-5.2%) | $20.49 B(-1.1%) |
| Dec 2014 | $20.70 B(+0.8%) | $5.05 B(-2.8%) | $20.70 B(-2.1%) |
| Sept 2014 | - | $5.19 B(-4.8%) | $21.16 B(+0.9%) |
| June 2014 | - | $5.46 B(+8.9%) | $20.97 B(+2.6%) |
| Mar 2014 | - | $5.01 B(-8.9%) | $20.43 B(-0.5%) |
| Dec 2013 | $20.55 B(-9.0%) | $5.50 B(+9.7%) | $20.55 B(-1.8%) |
| Sept 2013 | - | $5.01 B(+2.0%) | $20.93 B(-1.9%) |
| June 2013 | - | $4.92 B(-4.0%) | $21.33 B(-1.8%) |
| Mar 2013 | - | $5.12 B(-13.0%) | $21.73 B(-3.8%) |
| Dec 2012 | $22.58 B(-18.1%) | $5.88 B(+8.8%) | $22.58 B(-4.9%) |
| Sept 2012 | - | $5.41 B(+1.8%) | $23.74 B(-4.9%) |
| June 2012 | - | $5.31 B(-11.0%) | $24.95 B(-6.1%) |
| Mar 2012 | - | $5.97 B(-15.2%) | $26.59 B(-3.6%) |
| Dec 2011 | $27.57 B | $7.04 B(+6.4%) | $27.57 B(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $6.62 B(-4.7%) | $27.38 B(+0.9%) |
| June 2011 | - | $6.95 B(-0.1%) | $27.13 B(+0.8%) |
| Mar 2011 | - | $6.95 B(+1.4%) | $26.91 B(+0.1%) |
| Dec 2010 | $26.88 B(-0.6%) | $6.86 B(+7.6%) | $26.88 B(-1.5%) |
| Sept 2010 | - | $6.37 B(-5.2%) | $27.30 B(-2.0%) |
| June 2010 | - | $6.73 B(-2.8%) | $27.86 B(+0.8%) |
| Mar 2010 | - | $6.92 B(-4.9%) | $27.63 B(+2.2%) |
| Dec 2009 | $27.03 B(+8.1%) | $7.28 B(+4.9%) | $27.03 B(+4.6%) |
| Sept 2009 | - | $6.94 B(+6.8%) | $25.83 B(+3.0%) |
| June 2009 | - | $6.49 B(+2.8%) | $25.08 B(-0.1%) |
| Mar 2009 | - | $6.32 B(+3.9%) | $25.11 B(+0.4%) |
| Dec 2008 | $25.00 B(+8.1%) | $6.08 B(-1.8%) | $25.00 B(+0.2%) |
| Sept 2008 | - | $6.19 B(-5.1%) | $24.95 B(+1.8%) |
| June 2008 | - | $6.53 B(+5.1%) | $24.51 B(+3.0%) |
| Mar 2008 | - | $6.21 B(+3.0%) | $23.79 B(+2.8%) |
| Dec 2007 | $23.14 B(+10.6%) | $6.03 B(+4.9%) | $23.14 B(+2.0%) |
| Sept 2007 | - | $5.75 B(-1.0%) | $22.69 B(+2.6%) |
| June 2007 | - | $5.80 B(+4.4%) | $22.12 B(+2.4%) |
| Mar 2007 | - | $5.56 B(-0.3%) | $21.60 B(+3.3%) |
| Dec 2006 | $20.92 B(+12.5%) | $5.58 B(+7.7%) | $20.92 B(+3.4%) |
| Sept 2006 | - | $5.18 B(-2.1%) | $20.24 B(+3.2%) |
| June 2006 | - | $5.29 B(+8.5%) | $19.61 B(+2.5%) |
| Mar 2006 | - | $4.88 B(-0.5%) | $19.14 B(+2.9%) |
| Dec 2005 | $18.59 B(+14.5%) | $4.90 B(+7.8%) | $18.59 B(+3.3%) |
| Sept 2005 | - | $4.54 B(-5.7%) | $18.00 B(+3.2%) |
| June 2005 | - | $4.82 B(+11.2%) | $17.43 B(+4.7%) |
| Mar 2005 | - | $4.33 B(+0.7%) | $16.65 B(+2.6%) |
| Dec 2004 | $16.23 B(+12.8%) | $4.30 B(+8.1%) | $16.23 B(+3.0%) |
| Sept 2004 | - | $3.98 B(-1.4%) | $15.76 B(+2.4%) |
| June 2004 | - | $4.04 B(+3.1%) | $15.39 B(+4.7%) |
| Mar 2004 | - | $3.92 B(+2.4%) | $14.70 B(+2.2%) |
| Dec 2003 | $14.39 B(+8.0%) | $3.82 B(+6.0%) | $14.39 B(+1.1%) |
| Sept 2003 | - | $3.61 B(+7.8%) | $14.23 B(+3.3%) |
| June 2003 | - | $3.35 B(-7.2%) | $13.77 B(+0.7%) |
| Mar 2003 | - | $3.61 B(-1.7%) | $13.67 B(+2.7%) |
| Dec 2002 | $13.32 B(+10.8%) | $3.67 B(+16.6%) | $13.32 B(+3.4%) |
| Sept 2002 | - | $3.15 B(-3.2%) | $12.89 B(+2.1%) |
| June 2002 | - | $3.25 B(0.0%) | $12.62 B(+2.1%) |
| Mar 2002 | - | $3.25 B(+0.6%) | $12.36 B(+2.9%) |
| Dec 2001 | $12.02 B(+1.2%) | $3.23 B(+12.1%) | $12.01 B(+36.8%) |
| Sept 2001 | - | $2.89 B(-3.4%) | $8.78 B(+0.8%) |
| June 2001 | - | $2.99 B(+2.7%) | $8.71 B(+0.3%) |
| Mar 2001 | - | $2.91 B(+3.1%) | $8.69 B(-19.8%) |
| Sept 2000 | - | $2.82 B(-4.9%) | $10.83 B(-1.9%) |
| June 2000 | - | $2.96 B(+5.2%) | $11.04 B(-3.1%) |
| Mar 2000 | - | $2.82 B(+26.2%) | $11.39 B(+32.9%) |
| Dec 1999 | $11.89 B(+28.0%) | $2.23 B(-26.2%) | $8.57 B(+35.2%) |
| Sept 1999 | - | $3.03 B(-8.7%) | $6.34 B(+91.3%) |
| June 1999 | - | $3.31 B(+40.1%) | $3.31 B(+40.1%) |
| Dec 1998 | $9.29 B | - | - |
| June 1998 | - | $2.37 B(+121.2%) | $2.37 B(+121.2%) |
| June 1995 | - | $1.07 B | $1.07 B |
FAQ
- What is AstraZeneca annual gross profit?
- What is the all time high annual gross profit for AstraZeneca?
- What is AstraZeneca annual gross profit year-on-year change?
- What is AstraZeneca quarterly gross profit?
- What is the all time high quarterly gross profit for AstraZeneca?
- What is AstraZeneca quarterly gross profit year-on-year change?
- What is AstraZeneca TTM gross profit?
- What is the all time high TTM gross profit for AstraZeneca?
- What is AstraZeneca TTM gross profit year-on-year change?
What is AstraZeneca annual gross profit?
The current annual gross profit of AZN is $37.54 B
What is the all time high annual gross profit for AstraZeneca?
AstraZeneca all-time high annual gross profit is $37.54 B
What is AstraZeneca annual gross profit year-on-year change?
Over the past year, AZN annual gross profit has changed by +$5.58 B (+17.47%)
What is AstraZeneca quarterly gross profit?
The current quarterly gross profit of AZN is $10.48 B
What is the all time high quarterly gross profit for AstraZeneca?
AstraZeneca all-time high quarterly gross profit is $10.76 B
What is AstraZeneca quarterly gross profit year-on-year change?
Over the past year, AZN quarterly gross profit has changed by +$1.09 B (+11.57%)
What is AstraZeneca TTM gross profit?
The current TTM gross profit of AZN is $41.42 B
What is the all time high TTM gross profit for AstraZeneca?
AstraZeneca all-time high TTM gross profit is $41.42 B
What is AstraZeneca TTM gross profit year-on-year change?
Over the past year, AZN TTM gross profit has changed by +$5.28 B (+14.62%)